Visit COVID-19 resources

[Skip to Content]

Eye Journal

Trends in licence approvals for ophthalmic medicines in the United Kingdom – (Eye Journal)

Jan 03
2020

Eye, Published online: 03 January 2020; doi:10.1038/s41433-019-0758-7 Trends in licence approvals for ophthalmic medicines in the United Kingdom

  • 3 January 2020

Relationship between ocular involvement and clinical manifestations, laboratory findings, and coronary artery dilatation in Kawasaki disease – (Eye Journal)

Jan 03
2020

Eye, Published online: 03 January 2020; doi:10.1038/s41433-019-0762-y Relationship between ocular involvement and clinical manifestations, laboratory findings, and coronary artery dilatation in Kawasaki disease

  • 3 January 2020

Outcomes and complications of iris-fixated intraocular lenses in cases with inadequate capsular support and complex ophthalmic history – (Eye Journal)

Jan 03
2020

Eye, Published online: 03 January 2020; doi:10.1038/s41433-019-0759-6 Outcomes and complications of iris-fixated intraocular lenses in cases with inadequate capsular support and complex ophthalmic history

  • 3 January 2020

Effect of dark vs. white chocolate on the multifocal electroretinogram – (Eye Journal)

Jan 03
2020

Eye, Published online: 03 January 2020; doi:10.1038/s41433-019-0757-8 Effect of dark vs. white chocolate on the multifocal electroretinogram

  • 3 January 2020

Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration – (Eye Journal)

Jan 03
2020

Eye, Published online: 03 January 2020; doi:10.1038/s41433-019-0747-x Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration

  • 3 January 2020